Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - United States

United States

The revenue of the Diagnostic Imaging Devices market market in the United States is forecasted to reach €11.06bn in 2024.
It is anticipated that the revenue will experience an annual growth rate (CAGR 2024-2029) of 3.96%, leading to a market volume of €13.43bn by 2029.
When compared globally, the in the United States is expected to generate the highest revenue, with €11.06bn projected in 2024.
The United States is witnessing a growing demand for advanced diagnostic imaging devices in the medical technology market.

Key regions: Germany, Japan, Netherlands, Spain, United States

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Diagnostic Imaging Devices market in United States is experiencing significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Diagnostic Imaging Devices market in United States are driving the growth of the industry. Customers in the United States have a strong preference for advanced imaging technologies that provide accurate and detailed diagnostic information. They are willing to invest in high-quality imaging devices that offer improved imaging capabilities and faster scan times. Additionally, customers value devices that are user-friendly and offer seamless integration with other healthcare systems, such as electronic health records. As a result, manufacturers are focusing on developing innovative imaging devices that meet these customer preferences. Trends in the market are also contributing to the growth of the Diagnostic Imaging Devices market in United States. One major trend is the increasing adoption of digital imaging technologies. Digital imaging offers several advantages over traditional film-based imaging, including higher image quality, faster image acquisition, and easier storage and retrieval of images. As a result, healthcare facilities in the United States are upgrading their imaging equipment to digital systems, driving the demand for diagnostic imaging devices. Another trend in the market is the growing demand for portable and handheld imaging devices. These devices offer flexibility and convenience, allowing healthcare providers to perform imaging procedures at the point of care. This is particularly beneficial in rural areas or in emergency situations where access to traditional imaging equipment may be limited. The demand for portable and handheld imaging devices is expected to continue to grow in the United States, driving the overall market growth. Local special circumstances in the United States also contribute to the development of the Diagnostic Imaging Devices market. The United States has a well-established healthcare infrastructure, with a high number of hospitals and diagnostic imaging centers. This provides a strong customer base for diagnostic imaging devices and creates a favorable market environment for manufacturers. Additionally, the United States has a strong research and development sector, which encourages innovation and drives the development of new imaging technologies. Underlying macroeconomic factors also play a role in the growth of the Diagnostic Imaging Devices market in United States. The United States has a large and aging population, which increases the demand for diagnostic imaging services. As the population ages, the incidence of chronic diseases and conditions that require imaging diagnosis, such as cancer and cardiovascular diseases, is expected to rise. This drives the demand for diagnostic imaging devices in the United States. In conclusion, the Diagnostic Imaging Devices market in United States is developing due to customer preferences for advanced imaging technologies, trends in the market such as the adoption of digital imaging and portable devices, local special circumstances including a well-established healthcare infrastructure and strong research and development sector, and underlying macroeconomic factors such as a large and aging population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.